Celestone, Neofordex, Ozurdex (betamethasone) is a small molecule pharmaceutical. Betamethasone was first approved as Celestone on 1982-01-01. It is used to treat atopic dermatitis, facial dermatoses, foot dermatoses, hand dermatoses, and inflammation amongst others in the USA. It has been approved in Europe to treat macular edema, multiple myeloma, and uveitis. The pharmaceutical is active against glucocorticoid receptor.
|Trade Name||Neofordex, Ozurdex|
|Indication||atopic dermatitis, facial dermatoses, foot dermatoses, hand dermatoses, inflammation, leg dermatoses, macular edema, multiple myeloma, pruritus ani, psoriasis, scalp dermatoses, seborrheic dermatitis, uveitis|